Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Receptagen Ltd. -- Ignore unavailable to you. Want to Upgrade?

To: Russell J. Gilbert who wrote (137)	7/29/1998 1:55:00 PM
From: jack BROSS	Respond to of 203

HI RUSSELL.DON'T FORGET we had 20 millions debt it's still a chance that a financer is interested in rcg. but this financer squeeze himself in giving progressive loan to RCG. SO HE IS LIKE ME WHO BOUGHT 10 K DOLLARS AND LOST THEM, EXCEPT THAT HE LOANED 10 MILLIONS DOLLARS TO THE SHAREHOLDERS AND HE IS TRYING TO MULTIPLE BY 5 MAY BE HIS RISK IN THE TEN NEXT YEARS. FOR ME THE DEAL IS DONE WE CANNOT MAKE PRECONSOLIDATION PROFIT. we have to wait the value of the post consolidated share value.SO WHO IS THE NEXT SUCCER WHO WILL BUY THE GRN SHARE AT .,70 (REEL PRICE) OR 2.00 3.00 ? THE PROFIT WILL BE AFTER .70 BUT IT'S VERY RISKY THAT WE STAY AT .70 ,,,,,,,,,,,,,,,,SEE YOU JACK BROSS